Literature DB >> 8131569

Pneumonitis associated with natural and recombinant interferon alfa therapy for chronic hepatitis C.

K Chin1, C Tabata, N Sataka, S Nagai, F Moriyasu, K Kuno.   

Abstract

We report three cases of chronic hepatitis C (HC) with pneumonitis, suspected to be caused by natural and recombinant interferon (INF) alfa treatments. The patients were administered INF through intramuscular injection. All three patients developed acute respiratory failure (PaO2 < or = 60 mm Hg) with bilateral lung infiltration. One of the patient's condition improved after the cessation of INF treatment, without any other therapy. The other two patients were administered corticosteroids, and one patient's condition improved, while in the other patient the pneumonitis persisted, even after a high dose of corticosteroids. To our knowledge, these three cases are the first report of pneumonitis associated with INF alfa in patients with chronic HC.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8131569     DOI: 10.1378/chest.105.3.939

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

1.  The renin angiotensin system in liver and lung: impact and therapeutic potential in organ fibrosis.

Authors:  Amal Abdul-Hafez; Tarek Mohamed; Hanan Omar; Mohamed Shemis; Bruce D Uhal
Journal:  J Lung Pulm Respir Res       Date:  2018-02-27

Review 2.  Diagnosis and management of interstitial pneumonitis associated with interferon therapy for chronic hepatitis C.

Authors:  Fan-Pu Ji; Zheng-Xiao Li; Hong Deng; Hong-An Xue; Yuan Liu; Min Li
Journal:  World J Gastroenterol       Date:  2010-09-21       Impact factor: 5.742

Review 3.  Sarcoidosis after use of interferon for chronic hepatitis C: report of a case and review of the literature.

Authors:  V Tahan; F Ozseker; D Guneylioglu; A Baran; R Ozaras; A Mert; A C Ucisik; T Cagatay; D Yilmazbayhan; H Senturk
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

4.  Interstitial pneumonitis associated with pegylated interferon-alpha 2a and ribavirin for chronic hepatitis C infection: a case report.

Authors:  Ozlen Atug; Hakan Akin; Yesim Ozen Alahdab; Berrin Ceyhan; Nurdan Tozun; Osman Ozdogan
Journal:  Cases J       Date:  2009-03-10

5.  Expectoration of large bronchial casts secondary to the treatment of chronic hepatitis C with pegylated interferon and ribavirin.

Authors:  Evaldo Stanislau Affonso de Araújo; Aleia Faustina Campos; Juliana Yamashiro; Evandro Sobrosa Mello; Teresa Takagaki; Antonio Alci Barone
Journal:  Clinics (Sao Paulo)       Date:  2010-07       Impact factor: 2.365

6.  Severe interstitial pneumonitis secondary to pegylated interferon alpha-2b and ribavirin treatment of hepatitis C infection.

Authors:  Valentin Fuhrmann; Ludwig Kramer; Edith Bauer; Hermann Laferl; Gerhard Tucek; Gerhard Dekan; Peter Schenk
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

Review 7.  Pneumonitis as a consequence of (peg)interferon-ribavirin combination therapy for hepatitis C: a review of the literature.

Authors:  Serena Slavenburg; Yvonne F Heijdra; Joost P H Drenth
Journal:  Dig Dis Sci       Date:  2009-04-28       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.